 |
| The miraDry system--Courtesy of Miramar Labs |
California's Miramar Labs nailed down $10 million in new Series D funding that it will use to boost sales efforts for its CE marked medical device that eliminates sweat glands under the arms. Aisling Capital, Cross Creek Capital, Domain Associates, Morgenthaler Ventures and RusnanoMedInvest all participated in the round. Plans also call for using the money to back research and development for new products. The company's miraDry device is essentially a dermatology tool designed to deliver non-invasive energy to eliminate the sweat glands under the arm. The goal: to treat unwanted underarm sweat permanently. Miramar Labs launched in 2006. Item